Skip to main content
Log in
Home
All Courses
901. Health Services and Quality Improvement - Non-Malignant Conditions: Poster III
901. Health Services and Quality Improvement - Non-Malignant Conditions: Poster III
Summary
Course
Credit Activity Report
PARS log
More
Course info
Conferences and Meetings
901. Health Services and Quality Improvement - Non-Malignant Conditions: Poster III
901. Health Services and Quality Improvement - Non-Malignant Conditions: Poster III
Category:
Conferences and Meetings
Short name:
updated-901. Health Services and Quality Improvement - Non-Malignant Conditions: Poster III- 2023
Course start date:
01/12/2026
Enroll me
Sections
General
0 activities
901. Health Services and Quality Improvement - Non-Malignant Conditions: Poster III
0 activities
High Rate of Attendance at a Young Adult Clinic Embedded in an Adult Sickle Cell Center: If You Build It, They Will Come
1 activities
High Rate of Attendance at a Young Adult Clinic Embedded in an Adult Sickle Cell Center: If You Build It, They Will Come
Setting Cost-Effective Price Thresholds before FDA Approval: Cost-Effectiveness of Iptacopan Monotherapy Versus Standard-of-Care Anti-C5 Therapy in Tr
1 activities
Setting Cost-Effective Price Thresholds before FDA Approval: Cost-Effectiveness of Iptacopan Monotherapy Versus Standard-of-Care Anti-C5 Therapy in Tr
Abortions Outcomes of People with Sickle Cell Disease
1 activities
Abortions Outcomes of People with Sickle Cell Disease
A Novel Online Decision Support Tool to Determine Practice Patterns and Concordance with Experts in the Treatment of Patients with Immune Thrombocytop
1 activities
A Novel Online Decision Support Tool to Determine Practice Patterns and Concordance with Experts in the Treatment of Patients with Immune Thrombocytop
“Advancing a More Inclusive Blood and Transplant System for Marginalized Groups”: Development and Evaluation of a Transfusion Medicine Health Equity a
1 activities
“Advancing a More Inclusive Blood and Transplant System for Marginalized Groups”: Development and Evaluation of a Transfusion Medicine Health Equity a
Improving Treatment Adherence in Patients with Sickle Cell Disease
1 activities
Improving Treatment Adherence in Patients with Sickle Cell Disease
Underestimation of Venous Thromboembolism Risk: A Common Health Care Quality Deficit
1 activities
Underestimation of Venous Thromboembolism Risk: A Common Health Care Quality Deficit
Self-Sustainability with Therapeutic Phlebotomy, a Solution to the National Blood Crisis?
1 activities
Self-Sustainability with Therapeutic Phlebotomy, a Solution to the National Blood Crisis?
Assessing Pain Severity in Sickle Cell Disease Using Animations and a Graphical Body Image
1 activities
Assessing Pain Severity in Sickle Cell Disease Using Animations and a Graphical Body Image
Cost-Effectiveness of Emicizumab Vs Efanesoctocog Alfa, Standard Half Life (SHL) and Other Extended Half Life (EHL) FVIII Products for Prophylaxis in
1 activities
Cost-Effectiveness of Emicizumab Vs Efanesoctocog Alfa, Standard Half Life (SHL) and Other Extended Half Life (EHL) FVIII Products for Prophylaxis in
Taking Shared Decision Making from Concept to Clinical Practice: What Do Sickle Cell Healthcare Providers Need?
1 activities
Taking Shared Decision Making from Concept to Clinical Practice: What Do Sickle Cell Healthcare Providers Need?
Cost-Effectiveness of Caplacizumab in the Warranty Program in Immune Thrombotic Thrombocytopenic Purpura in the USA
1 activities
Cost-Effectiveness of Caplacizumab in the Warranty Program in Immune Thrombotic Thrombocytopenic Purpura in the USA
Establishing Mental Wellness Screening As Standard of Care in Pediatric Sickle Cell Patients
1 activities
Establishing Mental Wellness Screening As Standard of Care in Pediatric Sickle Cell Patients
Implementation of a Best Practice Alert and Dedicated Hematology Consultation on Hospitalization Outcomes of Patients with Sickle Cell Disease
1 activities
Implementation of a Best Practice Alert and Dedicated Hematology Consultation on Hospitalization Outcomes of Patients with Sickle Cell Disease
Disease-Modifying Therapies for Sickle Cell Disease: Decisional Needs and Supports Among Adolescents and Young Adults
1 activities
Disease-Modifying Therapies for Sickle Cell Disease: Decisional Needs and Supports Among Adolescents and Young Adults
Implementation of a Multipronged Intervention to Improvement Inpatient Sickle Cell Disease Care
1 activities
Implementation of a Multipronged Intervention to Improvement Inpatient Sickle Cell Disease Care
Standard Risk Assessment Tools Fall Short to Assess Risk in Transplant Patients
2 activities
Standard Risk Assessment Tools Fall Short to Assess Risk in Transplant Patients
Standard Risk Assessment Tools Fall Short to Assess Risk in Transplant Patients
Improving Access to Comprehensive Care for Pediatric Sickle Cell Patients through the Creation of Multispecialty Clinics
1 activities
Improving Access to Comprehensive Care for Pediatric Sickle Cell Patients through the Creation of Multispecialty Clinics
Assessment of Haemophilia Patients’ and Other Bleeding Disorders Needs of Psychosocial Support and Health Care Needs and Their Utilization in Haemophi
1 activities
Assessment of Haemophilia Patients’ and Other Bleeding Disorders Needs of Psychosocial Support and Health Care Needs and Their Utilization in Haemophi
Using a Quality Improvement Activity to Enhance the Knowledge, Competence and Confidence of Clinicians Managing Patients with Cold Agglutinin Disease
1 activities
Using a Quality Improvement Activity to Enhance the Knowledge, Competence and Confidence of Clinicians Managing Patients with Cold Agglutinin Disease
Exploring the Utility and Significance of an Adult Academic Non-Cancer Hematology Clinic
1 activities
Exploring the Utility and Significance of an Adult Academic Non-Cancer Hematology Clinic
Impact of Cancer Diagnosis on Appropriate Use of Antithrombotic Medications in Individuals with Cardiovascular Diseases
1 activities
Impact of Cancer Diagnosis on Appropriate Use of Antithrombotic Medications in Individuals with Cardiovascular Diseases
Facilitators and Barriers to Accessing Antifibrinolytic and Iron Therapies for Patients Who Menstruate – a Global Healthcare Provider Survey
1 activities
Facilitators and Barriers to Accessing Antifibrinolytic and Iron Therapies for Patients Who Menstruate – a Global Healthcare Provider Survey
Vimeo
24
Enroll me
Loading...
Help
Loading...
Accessibility
Text size
A-
A
A+
Color Adjustments
Monochrome
Low Saturation
High Saturation
High Contrast
Invert Colors
Change Hue
Reset Color Adjustments